Concepedia

Author

Vittoria Martin

Istituto Cantonale di Patologia

Also Known As

Vittoria Martin

35

Publications

893

Citations

17

H-Index

28

Concepts

All Affiliations

Istituto Cantonale di PatologiaInstitute of Oncology ResearchUniversity of InsubriaUniversity of BresciaEuropean Institute of Oncology
VM

About

Vittoria Martin is an author at Istituto Cantonale di Patologia specializing in medicine, cancer research, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

335

2

Pathology

7

7

280

3

Immunology

5

5

210

4

Cell Biology

3

3

101

5

Pharmacology

1

1

21

Vittoria Martin

×

20

Publications

782

Citations

16

H-Index

YearCitations

Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

Andrea Rinaldi, Ivo Kwee, Monica Taborelli,

British Journal of Haematology

2005

193

BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome

Maria Grazia Tibiletti, Vittoria Martin, Barbara Bernasconi,

Human Pathology

2009

109

NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levels

Alessandra Mozzi, Matilde Forcella, Alice Riva,

Glycobiology

2015

55

ALK Testing in Lung Adenocarcinoma: Technical Aspects to Improve FISH Evaluation in Daily Practice

Vittoria Martin, Barbara Bernasconi, Elisabetta Merlo,

Journal of Thoracic Oncology

2014

51

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study

Andrea Sartore‐Bianchi, Steffen Fieuws, Silvio Veronese,

Journal of Clinical Pathology

2011

39

Low prevalence of<i>Chlamydia psittaci</i>in ocular adnexal lymphomas from Cuban patients

Elías Gracia, Patrizia Froesch, Luca Mazzucchelli,

Leukemia & lymphoma/Leukemia and lymphoma

2006

38

EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect

Nora Sahnane, Milo Frattini, Barbara Bernasconi,

Clinical Lung Cancer

2015

36

EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer.

Vittoria Martin, E Zanellato, Alessandra Franzetti-Pellanda,

PubMed

2014

34

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Marco Siano, Francesca Molinari, Vittoria Martin,

The Oncologist

2017

32

Correlation of KRAS G12C Mutation and High PD-L1 Expression with Clinical Outcome in NSCLC Patients Treated with Anti-PD1 Immunotherapy

Marco Cefalì, Samantha Epistolio, Giulia Ramelli,

Journal of Clinical Medicine

2022

26

Page 1